Extension of Study ZPV-200
by on Friday, June 29th, 2012 | No Comments
Condition: Uterine Fibroids
Interventions: Drug: telepristone acetate 12 mg; Drug: telepristone acetate 3 mg; Drug: telepristone acetate 6 mg; Drug: telepristone acetate 12 mg; Drug: telepristone acetate 24 mg
Sponsors: Repros Therapeutics Inc.; Repros Therapeutics Inc.
Not yet recruiting – verified June 2012
Continued here: Extension of Study ZPV-200